New combo therapy aims to stall liver cancer progression
NCT ID NCT05620771
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for adults with advanced liver cancer (hepatocellular carcinoma) that is hard to treat. It compares two standard drug regimens — immunotherapy (atezolizumab + bevacizumab) or targeted pills (lenvatinib or cabozantinib) — given after a liver-directed radiation treatment called Therasphere (Y-90). The goal is to see which combination better delays cancer growth. About 200 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Northwestern Medicine Delnor Hospital
RECRUITINGGeneva, Illinois, 60134, United States
Contact Email: •••••@•••••
-
Northwestern Medicine Grayslake Outpatient Center
RECRUITINGGrayslake, Illinois, 60030, United States
Contact Email: •••••@•••••
-
Northwestern Medicine Kishwaukee Hospital
RECRUITINGDeKalb, Illinois, 60115, United States
Contact Email: •••••@•••••
-
Northwestern Medicine Lake Forest Hospital
RECRUITINGLake Forest, Illinois, 60045, United States
Contact Email: •••••@•••••
-
Northwestern Medicine Orland Park
RECRUITINGOrland Park, Illinois, 60462, United States
Contact Email: •••••@•••••
-
Northwestern Medicine Warrenville
RECRUITINGWarrenville, Illinois, 60555, United States
Contact Email: •••••@•••••
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?